pr dr abu

Embed Size (px)

Citation preview

  • 8/12/2019 pr dr abu

    1/10

    ANTIBIOTIC REVIEW SHEET

    Antibiotic(classification)

    Mechanism Resistance Antibacterial

    Spectrum

    Side Eects Metabolism !istribution

    Adm" # CNS

    Anti$M%cobacterial !ru&s'

    (TB Treatment)!ue to dru& resistanc( combo therap% is recommende )i"e" isonia*id( riampin( and p%ra*inamide +ith ethambutole i resistance to isonia*id is , -./

    Isonia*id(bactericidal) Activated by

    mycobacterial KAT G (a catalaseperoxidase). It binds to InhA (an enoylacyl carrier protein NAD red!ctase).

    InhA is involved in mycolic acidsythesis and hence inhibits cell "allsynthesis.

    #!tation in InhA.

    $oss of KAT G activity

    It penetrates macropha%es and is

    effective a%ainst intra and extre&cell!lar or%anisms#ycobacteria

    Kansasii

    'eripheral ne!ritis

    $iver dama%eGlossitisGI dist!rbance

    Aller%ic rxnN reversed by pyridoxine

    (*&+ ho!rs) lon% or short is

    %enetically determined (ethnic)Activity of hepatic&N&acetyltransferase inactivaiton

    ,xcreted via -idney

    ral

    Dr!% interaction/Al!min!m antacid

    decreases absorption.Decreases '012

    phenytoin toxicity

    3es

    Riampin

    (bactericidal) Inhibits initiation of

    transcription by bindin% to the s!b!nitof bacterial 4NA polymerase

    #!tation of 4NA polymerase

    res!ltin% in affinity or permeability

    $eprae

    Kansasii

    ran%e5red feces6 !rine6

    saliva6 and s"eat$iver dama%eGI dist!rbanceAller%y

    (7&1 ho!rs8 deacylation) ,xcreted

    in bile and enterohepaticcirc!lation

    ral

    Dr!% interaction/'012ther dr!% activity("arfarin6 prednisone6contraception6

    methadone)

    Ethambutol(bacteriostatic) Inhibits arabin o%alactan

    sythesis (cell "all). Th is "ea-ens the"all and enhances lipophillic dr!%s li-e4ifampin

    9n-no"n T!berc!losis

    #AKansasii

    ptic ne!ritis

    vis!al ac!ityred %reen visionaller%ic rxnexacerbate %o!t6 b!t less than

    pyra:inamide

    (0 ho!rs) !nchan%ed

    -idney

    oral

    0%ra*inamide(bactericidal) 9n-no"nydroly:ed into its active form6

    pyra:inoic acid. Tho!%ht to tar%et fattyacid synthase I6 "hich converts%lycolipid to mycolic acid. ence6 thecell "all is affected

    $oss of pyra:in amidase action6"hich activates pyra:inamide.

    'enetrates the macropha%elysosome beca!se it operates best

    at lo" pT!berc!losis

    $iver dama%eGI dist!rbance

    ,xacerbates %o!t more thanethamb!tol

    Kidney ral

    Streptom%cinInhibits bacterial protein synthesis by

    bindin% to ribosomes

    'oint m!tation in ribosome 'oor diff!sion across plasma

    membrane. ence6 it only affectsextracell!lar t!berc!losis.

    ;estib!lar f!nctionearin% loss

    Aller%ic rxn4ash4enal dama%e

    (+ ho!rs) 9nchan%ed

    Kidney

    I#

    Riabutin(bactericidal) Inhibits initiation of

    transcription by bindin% to the s!b!nitof bacterial 4NA polymerase

    #!tation of 4NA polymerase

    res!ltin% in affinity or permeability

    Atypical mycobacteri!m that

    affects I; &*2 days in anephric pt.8not removed by hemodialysis.

    I;

    If %iven rapidly6ca!ses fl!shin%(histamine release).

    C%loserine)inhibits cell +all

    s%nthesis/

    Inhibits ala "acemase (prevents $&ala

    D&ala) andDala Dala Synthetase(D&ala D&ala formation)d!rin%cytoplasmic synthesis phase.

    Bacteriocidal.

    1contraindicated in pt5s +ith

    histor% o epileps% or mental

    instabilit%"

    *. N effects (conf!sion6coma)7. 'eripheral ne!ritis.

    +. $iver dama%e.0. olate deficiency.1. #alabsorption syndrome.

    ral N

    Bacitracin)inhibits cell +all

    s%nthesis/

    Inhibits re%eneration of the lipid carrier6

    "hich is responsible for transportin%peptido%lycan prec!rsors across the cellmembrane..

    Bacteriocidal. 9sed topically b5c

    oral !se is toxic.

    Streptom%cin)inhibits protein

    s%nthesis/

    Binds at5near domain of *7 protein on

    bacterial +2. *. Allo"s 2 initiationcomplex to form b!t inhibits it frommovin% alon% m4NA. 7. prevents

    peptide elon%ation (prevents bindin% of

    aminoacyl t4NA) +. disr!pts bacterialcell membrane*selectivity= %s only in bacteria

    *. #!tation in *7 protein in +2

    s!b!nit7. 'lasmid mediated acetylation6

    adenylation6 F phosphorylation

    inactivates the dr!%.

    Bacteriocidal.

    1 has lo+ TI must monitor6

    to2icit% +# prolon&ed use )78$9

    da%s/6 to2icit% +# CN VIII"

    11used rarel% b#c lots o

    resistance to it no+"

    *. Vestibular toxicity

    (di::iness6 verti%o) Oototo2icit% (deafness).7. Nephroto2icit%"+. M%oneural bloc:ade

    rare0. 4ash5fever post parenteraladministration.

    No metabolism.

    ,xcretion by %lomer!lar filtration.

    T J 7 hrs. ("5 renal dx F a%e)

    adH!st dose.elective acc!m!lation in 'T of-idney6 endo F perilymph of haircells.

    $imited F slo" oral

    absorption.#!st be %iven

    parenteral (I;) inC#.Acc. in ple!ral6

    pericardial6 synovialfl!ids F fet!s.

    $ittle

    penetration.

    *

  • 8/12/2019 pr dr abu

    2/10

    !apsone

    'ABA a%onist. ence6 folic acid

    biosynthesis is bloc-ed. 'rod!ction ofmethionine6 serine6 p!rines6 and N formlmet 4NA are inhibited

    C'ABA,n:yme m!tation

    $eprae 4ash

    emolytic anemiaGI dist!rbance$iver dama%e

    'eripheral ne!ropathy

    ,limiated in free form and

    %l!c!ronideKidney

    ral

    Cloa*imine

    Binds to DNA and inhibits templatef!nction and prod!ction of cytotoxic

    oxy%en radicals.

    Ne". ence6 fe" cases -no"n $eprae 4ed discolori:ation o s-in6!rine6 sp!t!m6 and s"eat

    GI dist!rbance

    ral

    Thalidomide

    9n-no"n

    Gl!tamin acid derivativeIt has anti&inflammatory and imm!no&mod!latin% effects

    Ne" ,rethema

    Nodos!m lepros!m$eprae

    Terato%en

    'eripheral ne!ropathyedationonstipation

    9n-no"n ral

    Anti$;un&al A&ents'

    Antibiotic

    (classification) Mechanism Resistance

    Antibacterial

    Spectrum Side Eects Metabolism

    !istribution

    Adm" # CNS

    Amphotericin B

    (polyene)

    Binds to er%osterol of the cell membraneand ma-es a pore that allo"s ionic fl!xand cell lysis

    4are 9sef!l a%ainst all f!n%i6 b!t !selimited to systemic'ro%ressive infections

    $ife threatenin% infectionAsper%ill!s

    Ac!te febrile rxn !poninf!sion4enal dama%e

    A:otemiaypo-alemiaThrombophlebitisAnorexia

    M2 protein bo!nd lo" I; No

    N%statin

    (polyene)

    Binds to er%osterol of the cell membraneand ma-es a pore that allo"s ionic fl!xand cell lysis

    4are !perficial mycosis#ostly candida

    Aller%ic rxnGI dist!rbance

    Topical No

    ;luc%tosine

    (pyrimidine)

    Deaminated by cytosine deaminase to 1

    fl!oro!racil and anaboli:ed into an!cleotide6 1&d9#' or 1&9T'. Then!cleotide binds to thymidilatesynthetase and deprives the cell of

    thymidilic acid6 an essential DNAcomponent. 1 &9T' incorporates into4NA and disr!pts n!cleic acid and

    protein synthesis.

    $oss of cytosine permease

    9#' phophorlyase or cytosine deaminase

    rytococc!s Neoformans

    ome candidahromobastomycosis(dermitacio!s mold)

    Intestinal conversion to

    fl!oro!racil ca!ses bonemarro" toxicity6 le!-openia6thrombocytopeniaGI dist!rbance

    9nchan%ed

    Kidney

    ral 3es

  • 8/12/2019 pr dr abu

    3/10

    Clotrima*ole

    (imida:ole)

    (!n%icidal) 4ed!ction of er%osterol

    synthesis by inhibition of f!n%al '012.

    The sterol affected is *0 demethylase.The res!lt is a disr!ption of themembrane permeability and f!nction.

    !perficial mycosis ,rythema

    'r!ritisB!rnin%GI irritation

    Topical

    ral

    Anti$;un&al A&ents' )continued/

    Antibiotic(classification)

    Mechanism ResistanceAntibacterial

    SpectrumSide Eects Metabolism

    !istribution

    Adm" # CNS

    Micona*ole

    (imida:ole)

    (!n%icidal) 4ed!ction of er%osterol

    synthesis by inhibition of f!n%al '012.The sterol affected is *0 demethylase.The res!lt is a disr!ption of themembrane permeability and f!nction

    !perficial mycosis B!rnin%

    Irritation

    Topical

    ;lucona*ole

    (tria:ole)

    (!n%icidal) 4ed!ction of er%osterolsynthesis by inhibition of f!n%al '012.

    The sterol affected is *0 demethylase.The res!lt is a disr!ption of themembrane permeability and f!nction.

    ral and esopha%eal candidiasis!perficial mycosis ("idest of

    a:oles)ryptococcal menin%itisDimorphic f!n%i

    Q side effects than imida:oleNo interaction "ith liver

    en:ymeGIypo-alemia

    ,demaypertension

    9nchan%edKidney

    ralI;

    3es

    Itracona*ole

    (tria:ole)

    (!n%icidal) 4ed!ction of er%osterolsynthesis by inhibition of f!n%al '012.

    The sterol affected is *0 demethylase.The res!lt is a disr!ption of themembrane permeability and f!nction.

    Dimorphic/ blastomycosis6histoplasma6 sporothrix#ost potent of tria:ole6 b!t

    bioavailability Q "th rifampin

    Asper%ill!sDermatophytosis

    nchomycosis

    Interat "ith some hepaticen:ymesGIypo-alemia

    ,demaypertension

    $iver,xcreted in bile and !rine

    ral

    Terbinaine

    (allylamine)

    Inhibits the en:yme sP!aline epoxidase"hich inhibits er%osterol prod!ction and

    cell "all inte%rity

    !perficial mycosisR* dermatophyte

    nchomycosis

    Irritation Topical

    =riseoul4in

    (%risan)

    #ytotic inhibitorBinds to microt!b!les to bloc- assemblyand f!nction

    !perficial mycosis GI dist!rbanceAller%ic rxn'hotosensitivityInd!ce '012. o"ever6 it

    tar%ets -eratin cells andeffects are minimaleadache

    $iver,xcreted in feces and !rine

    ral

    0entamidine

    'ne!mocystic carinni pne!moniaBlastomycosis

    Ato4a>uone

    'ne!mocystic carinni pne!moniaBlastomycosis

    +

  • 8/12/2019 pr dr abu

    4/10

    0

  • 8/12/2019 pr dr abu

    5/10

    Cell Wall Inhibitors'

    Antibiotic(classification)

    Mechanism ResistanceAntibacterial

    Spectrum Side Eects Metabolism!istribution

    Adm" # CNS

    0enicillin =

    & idal

    ?/Inhibits peptido&l%can transpeptidase(a 'B' that forms crosslin-s b5t

    NA#5NAG in the cell "all)& mimics the D&ala&D&ala end of NA#

    (!s!al s!bstrate) bindin% covalently to theen: and inhibitin% it@/activates endo%eno!s a!tolytic en:ymemurein h%drolase "hich de%rades the cell

    "all f!rther

    Beta$lactamase

    & hydroly:es the beta&lactambond& most common esp in Gpos& Gpos secrete o!tside cell "all

    & Gne% -eep in periplasmicspace!ecreases perm to 0EN

    & Gne% can chan%e the porin so

    it dosent let ',N inAlterations in 0B0s!ch asalterin% the transpeptidases L ex

    is #4A

    Narro" pectr!m

    & 'rimarily activea%ainst =pos

    aerobesandanaerobes

    o+ direct to2icit%b5c tar%et is spec to bact

    & GI6 Thrombophelbitis after I;6 N "5 very hi%h doses6 !perinf (.enterocolitis)6 pse!domembrano!s colitis6 Ne!tropenia6,lectrolyte imbalance (K

  • 8/12/2019 pr dr abu

    6/10

    Antibiotic(classification)

    Mechanism ResistanceAntibacterial

    SpectrumSide Eects Metabolism

    !istribution

    Adm" # CNS

    Ciprolo2acin

    (fl!oroP!inolone)

    Inhibit DNA Gyrase and Topoisomerase #!tation in Gyrase,ffl!x

    Gram Ne%Gram 'os not some anaerobes

    #ycobacteria

    Inhibit GABAN effects

    4,NA$ ral N ,,T

    Norlo2acin

    (fl!oroP!inolone)

    Inhibit DNA Gyrase and Topoisomerase #!tation in Gyrase,ffl!x

    Gram Ne%'oor tiss!e penetration

    9TI only

    Inhibit GABAN effects

    4,NA$ ral N ,,T

    Nitrourantoin

    (!nrinaryantiseptic)

    9n-no"n

    DNAUxy%en free radicalU

    lo" resistance

    4are

    Gram 'ost

    e" Gram Ne%

    Not 'se!domonas or 'rote!s

    Bro"n 9rine

    Na!sea and ;omitin%'!lmonary ibrosis

    4,NA$ ral

    Methenamine(!rinary

    antiseptic)

    Decomoses at p V1.1 to

    4#A$D,3D,

    4are #ost Bacteria

    ,xcept !rease splittin% bacteriaie. 'rote!s

    Toxic to GI

    Bladder irritation

    4,NA$ ral

    >

  • 8/12/2019 pr dr abu

    7/10

    ;luoro>uinilones and Drinar% Antiseptics'

    Amino&l%cosides'

    Tetrac%clines'

    Antibiotic(classification)

    Mechanism ResistanceAntibacterial

    SpectrumSide Eects Metabolism

    !istribution

    Adm" # CNS

    =entamicin

    Inhibit +2 Decrease 9pta-e Gram Ne%

    yner%y "ith Beta $actams

    totoxic

    Nephrotoxic;estib!lar

    4,NA$ I;

    Neom%cin

    Inhibit +2 +2 m!tation4arely active a%ainst Gram 'os

    T'IA$ 4INT,TINA$ $4A

    Too nephrotoxic forparenteral

    Intestinal #alabsorption(not absorbed "ell)

    eces T'IA$

    4A$ for red!cin%intestinal flora

    Streptom%cin

    Inhibit +2 Decrease 9pta-e

    ,xtensive 4esistance4arely !sed b!t for TB

    TB totoxicNephrotoxic;estib!lar

    4,NA$ I;

    Ami:acin

    Inhibit +2 Decrease 9pta-e Gram Ne%yner%y "ith Beta $actams

    'otent a%ainst 'se!domonas

    totoxicNephrotoxic

    ;estib!lar

    4,NA$ I;

  • 8/12/2019 pr dr abu

    8/10

    Miscellaneous Anti$Bacterial !ru&s'

    Antibiotic(classification)

    Mechanism ResistanceAntibacterial

    SpectrumSide Eects Metabolism

    !istribution

    Adm" # CNS

    Chloramphenicol

    binds 12 and

    inhibits peptidyltransferaseno

    protein elon%ation

    'lasmid ma-es AT

    (cholrampenicolacetyl transferase)

    acetylation

    inactivation

    Ne4er irst choice6

    b!t !sed forsalmonella6 h. fl!

    (menin%ial inf.) and

    GN aerobes that

    ca!se brain abscesses

    4apid and complete

    absorption6 especiallyto N6 inhibits p0126

    ca!ses hepatic

    ins!fficeintcy

    ,xcreted M2 as

    non&toxic%l!c!ronide by

    t!b!lar secretion6

    *2 as parent

    dr!%

    phthalmic

    sol!tion andointment

    3es L !sed

    for treatmentof menin%ial

    infections and

    brain abcesses

    Er%throm%cin

    )EM/

    Binds $*1 protein

    of 12 and bloc-s

    translocation from

    the A site to the '

    site

    'lasmid/

    methylation6 decrease

    permeability6

    hydrolysis by

    esterases

    hromosomal/

    alternation of 12s

    protein at ,#&bindin% site

    *. cornyinfections

    7. chlamydial

    infections

    +. A pne!monia

    Gram positives

    (pneumococci strep

    staphand corny)8

    pne!monia frommycoandle&ionella

    Abdominal crampin%6

    increase stomach

    motility6 cholestatic

    hepatitis6 ototoxicity

    Activity

    enhanced at

    al-aline p8

    absorption

    inhibited by

    food8

    concentrated in

    liver andexcreted in bile

    rally or

    parentally

    (I; as ,#

    %l!ceptate

    or ,#

    lactobionate

    )

    No

    Clarithrom%cin Binds $*1 proteinof 12 and bloc-s

    translocation from

    the A site to the '

    site

    'lasmid/

    methylation6 decrease

    permeability6

    hydrolysis by

    esterases

    hromosomal/

    alternation of 12s

    protein at ,#&

    bindin% site

    ombo therapy for

    AID6 #A (myco

    avium)6strepand

    mycoand le&ionella

    pne!monia

    GI probs6 inhibits p0126

    terato%enic

    More stable to

    acid than EM(

    lon&er hal lie

    than ,#

    t"ice daily

    dosin%8

    metaboli:ed in

    liver6 excreted

    by -idney

    rally No

    A*ithrom%cin Binds $*1 protein

    of 12 and bloc-stranslocation from

    the A site to the '

    site

    'lasmid/

    methylation6 decreasepermeability6

    hydrolysis by

    esterases

    hromosomal/

    alternation of 12s

    protein at ,#&

    bindin% site

    ombo therapy for

    AID6 #A strep6mycoand le&ionella

    pne!monia6

    chlamydia

    GI6 reversible hearin%

    loss "hen !sed to treat#A

    No inhibition o p-9

    nce daily

    dosin%( no dru&$dru&

    interactions

    orally No

    Tetrac%cline

    Inhibit +2 at A& ite Decrease 9pta-eIncrease ,$9W

    #!tation +2

    Gram 'osGram Ne%

    GIBROWN TEETH

    !perinfection

    4ed!ce bioavail. f ral

    ontraceptives

    a ion6 antacids and foodInhibit absorption

    4A$

    !o2%c%cline

    Inhibit +2 at A& ite Decrease 9pta-eIncrease ,$9W#!tation +2

    Gram 'osGram Ne%

    GI

    4ed!ce bioavail. f ralontraceptives

    a ion6 antacids and foodInhibit absorption

    #ore $ipid sol!ble

    $o" renal clearance

    4A$

    Minoc%cline

    Inhibit +2 at A& ite Decrease 9pta-eIncrease ,$9W

    #!tation +2

    Gram 'osGram Ne%

    GI

    Vestibular

    4ed!ce bioavail. f ral

    ontraceptives

    a ion6 antacids and foodInhibit absorption

    #ore $ipid sol!ble$o" renal clearance

    Retained in lipids and CNS

    4A$

    X

  • 8/12/2019 pr dr abu

    9/10

    Clindam%cin

    )CM/

    Binds $*1 protein

    of 12 and bloc-s

    translocation from

    the A site to the '

    site

    'lasmid/

    methylation6 decrease

    permeability6

    hydrolysis by

    esterases

    hromosomal/

    alternation of 12s

    protein at ,#&

    bindin% site

    Anaerobic infections

    (b. fra&ilis) staph

    andstrep

    'rophylaxis of

    endocarditis "5

    valv!lar heart

    disease8 penetratin%

    "o!nds

    pse!domembrano!s

    colitis (c. difficile)

    Absorbed in

    liver

    rally and

    parentally

    No

    Metronida*ole

    )MTN/

    In anaerobes6

    bacterial

    nitrored!ctase

    forms red!ced

    #TN "hich

    disr!pt bacterial

    DNA

    $o" nictrored!ctase

    lo" red!ced #TN

    red!ced bacterial

    disr!ption

    $. +iardiasis

    ,mebiasis

    Trichomoniasis-

    7. Anaerobic

    infections (b.

    fra&iles)

    + pse!domembrano!s

    colitis from c.

    difficile

    Metallic taste6 na!sea6

    headache6

    dar: reddish$bro+n

    urine(

    inhibits p012

    #etaboli:ed by

    liver

    oral 3es

    ine*olid

    Binds 7+ of 12

    and prevents

    formation off!nctional 2

    4are/ m!tation of

    bindin% site

    ast resort

    treatment for

    vancomycin&resistantenterococcus staph

    andstrep (%ram

  • 8/12/2019 pr dr abu

    10/10

    Alcohol and Related !ru&s'

    Antibiotic(classification)

    Acute 0h%sical

    Eects#MechChronic Eects

    !ru&

    InteractionsMetabolism CNS

    Ethanol

    Beha4ioral

    & edation6 inhibition loss6 impaired H!d%ment6 sl!rredspeech6 ataxia

    12&X2 m%5d$ drivin% impairment

    *72&*>2 m%5d$ dr!n-enness O122 m%5d$ death0eripheral Eects

    & cardiac fcn6 relaxes vasc!lar (and !terine) smoothm!scle vasodilation6 hypothermia& hypo%lycemic action of s!lphonyl!reas and antiplatelet action of aspirin

    Central Eects

    $ =ABAAreceptorL a li%and %ated ion channel (l&)

    & conc ,t effects of maHor inhibitoryne!rotransmitter (GABA)

    $ =lutamateresponses (N#DA rec) are inhibited by

    ,tne!ronal excitability& ,xcitation mediated by 9$HT8 serotonin recemetic response (na!sea5vomitin%)

    Tolerence

    & #etabolic ('harm -inetic) L ind!ction of metabolic en:expression& !nctional ('harm Dyn) L red!ction of the N sensivity to

    adaptive chan%es in ne!rons& ross&tolerance to other sedative&hypnotic dr!%s& 'hysical dependance

    0eripheral

    & $iver/ hypo%lycemia F fat acc!m!lation (NAD depletion)6

    liver dama%e6 '012 en:& GI/ irritation6 scarin% of %!tabsorption deficits& ,ndocrine/ Gynecomastia6 testic!lar atrophy6 salt retention 7 to altered steroid met in cirrhotic liver& ;/ TTN6 anemia6 #I

    & Neoplasia/ ,t not a * carcinogen, but coincidence ofcarcinomas

    Ner4ous s%s

    & most common 'eripheral ne!ropathies

    & less often L thiamin def. Wernic:e$